Prosoma
PrivateLast Round
Series A
Jan 20, 2025
Total Funding Raised
$9.87M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Prosoma operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in January 2025.
Prosoma is a health technology company that develops digital therapeutics and behavioral support platforms for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Patient Engagement, Medical Devices, Telemedicine
Business Model
B2G
Customer Profile
Government Contracts, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prosoma Comparables
Compare Prosoma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fosanis GmbH | 85% | |
| mika AI | 83% | |
| Tired of Cancer BV | 83% |
For institutional investors. Book with your work email.
Prosoma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 20, 2025 | ||||
| Seed | Dec 22, 2022 | ||||
| Grant | Dec 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prosoma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Convergence Partners AG | Series A |
| Pomerangels | Seed |
| YouNick Mint | Seed |
| Impact Ventures | Series A |
| EIT Health | Grant |
| Balnord | Seed |
| Smartlink Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2026
Open roles increased to 8, 2.5x the trailing average.
- Oct 12, 2026
Open roles increased to 6, 2.6x the trailing average.
For institutional investors. Book with your work email.
Prosoma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Prosoma's valuation, stock price, and market status.
Is Prosoma a public or private company?
Prosoma is a private company.
What is the current stock price of Prosoma?
Prosoma is a private company, so its shares have no public market price. Caplight tracks Prosoma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prosoma worth (valuation)?
Valuation information for Prosoma is not publicly available.
Can I buy Prosoma stock?
Prosoma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prosoma's last funding round?
Prosoma's most recent funding round was Series A on January 20, 2025.
Who are the main investors in Prosoma?
Key investors in Prosoma include YouNick Mint, Impact Ventures, Verge HealthTech Fund, Simpact Ventures, Impact Ventures.
Will Prosoma IPO soon?
No public IPO plans have been announced for Prosoma.
How can I track Prosoma secondary market activity?
Caplight tracks bids, offers, and trades in Prosoma's shares on secondary markets.